Vanguard Personalized Indexing Management’s Ascendis Pharma A/S ASND Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$499K	Buy	1,870 +445	+31%	+$104K	﹤0.01%	1398
2026 Q1	$326K	Sell	1,425 -33	-2%	-$7.4K	﹤0.01%	1565
2025 Q4	$311K	Buy	1,458 +2	+0.1%	+$413	﹤0.01%	1505
2025 Q3	$289K	Buy	1,456 +130	+10%	+$24.2K	﹤0.01%	1521
2025 Q2	$229K	Buy	1,326 +10	+0.8%	+$1.63K	﹤0.01%	1566
2025 Q1	$205K	Sell	1,316 -182	-12%	-$26K	﹤0.01%	1515
2024 Q4	$206K	Buy	1,498 +34	+2%	+$4.47K	﹤0.01%	1510
2024 Q3	$219K	Buy	+1,464	New	+$198K	﹤0.01%	1489

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Personalized Indexing Management's ASND Position: Q2 2026 in Review

Vanguard Personalized Indexing Management increased its Ascendis Pharma A/S (ASND) stake by 31% in Q2 2026, buying an estimated $104K and bringing the position to 1,870 shares worth $499K. The position accounts for ﹤0.01% of the portfolio, ranked #1398.

Vanguard Personalized Indexing Management first reported a position in ASND in Q3 2024 and has held it in 8 quarters since. 311 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Vanguard Personalized Indexing Management held 1,870 shares of Ascendis Pharma A/S worth $499K as of Q2 2026.
Vanguard Personalized Indexing Management bought 445 Ascendis Pharma A/S shares in Q2 2026, an estimated $104K.
Ascendis Pharma A/S made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #1398 holding.
Vanguard Personalized Indexing Management first reported a position in Ascendis Pharma A/S in Q3 2024 and has held it in 8 quarters since.
311 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.